| Income Statement |
| Operating Expenses | 28.77M |
|
| Research and Development Expense | 19.49M |
| Selling, General and Administrative Expense | 9.28M |
| Operating Income | -28.77M |
| Income Tax Expense | -1.22M |
| Net Income | -25.82M |
| Net Income Common Stock | -25.82M |
| Net Income Common Stock (USD) | -25.82M |
| Consolidated Income | -25.82M |
| Earnings per Basic Share | -0.20 |
| Earnings per Basic Share (USD) | -0.20 |
| Earnings per Diluted Share | -0.20 |
| Earning Before Interest & Taxes (EBIT) | -27.05M |
| Earning Before Interest & Taxes (USD) | -27.05M |
| Weighted Average Shares | 127.71M |
| Weighted Average Shares Diluted | 127.71M |
| Balance Sheet |
| Cash and Equivalents | 187.65M |
| Cash and Equivalents (USD) | 187.65M |
| Current Assets | 191.59M |
| Property, Plant & Equipment Net | 153.00K |
| Total Assets | 194.63M |
| Current Liabilities | 16.97M |
| Total Liabilities | 16.97M |
| Accumulated Retained Earnings (Deficit) | -300.90M |
| Shareholders Equity | 177.66M |
| Shareholders Equity (USD) | 177.66M |
| Assets Non-Current | 3.04M |
| Trade and Non-Trade Payables | 16.97M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 20.00K |
| Net Cash Flow from Financing | 2.05M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.48M |
| Capital Expenditure | -36.00K |
| Issuance (Purchase) of Equity Shares | 2.18M |
| Net Cash Flow from Investing | -36.00K |
| Net Cash Flow from Operations | -19.50M |
| Share Based Compensation | 5.32M |